IMA910 Plus GM-CSF With Low-dose Cyclophosphamide Pre-treatment in Advanced Colorectal Carcinoma Patients Following a Successful 12 Week First-line Treatment With Oxaliplatin-based Chemotherapy (IMA910-101)

This study is ongoing, but not recruiting participants.

Study NCT00785122 Information provided by immatics Biotechnologies GmbH

First Received: November 4, 2008 Last Updated: February 1, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2012
Primary Completion Date:	January 2011 (Final data collection date for primary outcome measure)